Genoma Research Group, Inc.

Miami, Florida 66135

2 studies enrolling now · 18 studies all time

What they study most

Alzheimer Disease, Cirrhosis, Contraception, Healthy Volunteers, Irritable Bowel Syndrome Characterized by Constipation, Lumbar Disc Herniation, Menopausal Symptoms, Metabolic Dysfunction-Associated SteatoHepatitis (MASH), Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Metabolic Dysfunction-assocated Steatohepatitis/ Nonalcoholic Fatty Liver Disease, Mild Cognitive Impairment, NASH - Nonalcoholic Steatohepatitis

Studies at this site

• A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition — Recruiting now
• A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) — Recruiting now
• Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH) — Running, not enrolling
• Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis — Stopped early
• Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive — Stopped early
• A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD) — Running, not enrolling
• SI-6603 (Condoliase) Study for Lumbar Disc Herniation (Discovery 6603 Study) — Completed
• Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH) — Completed
• Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria — Completed
• Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort Study I) — Completed
• Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy, Compared With Placebo in Adult Patients With NASH and Liver Fibrosis. — Stopped early
• Genetic Data Collection in Adult Participants to Identify Genetic Variants of Known Importance in Non-alcoholic Steatohepatitis (NASH) — Stopped early
• Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis — Status unconfirmed
• Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 4) — Stopped early
• AURORA: A Study for the Efficacy and Safety of Cenicriviroc (CVC) for the Treatment of Liver Fibrosis in Adults With Nonalcoholic Steatohepatitis (NASH) — Stopped early
• Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis — Stopped early
• Different Doses of BI 1467335 Compared to Placebo in Patients With Clinical Evidence of NASH — Completed
• The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C) — Completed